The BJC provides a forum for clinicians and scientists to communicate original research findings that have relevance to understanding the etiology of cancer and to improving patient treatment and survival.

Cancer Research Campaign began partnering with Nature as publisher of the journal in the 1980s, but retained ownership and editorial control.

In 2021, after the charity experienced a fall in charitable income during the COVID-19 pandemic, Cancer Research UK sold the journal to Springer Nature.

[4] SJR ranked BJC as 30th journal in cancer research with H-index 224.

[5] BJC is a top cited general cancer journal committed to publishing cutting edge discovery, translational and clinical cancer research.